IISc’s Mynvax is effective against all major variants of concern: study-Business Journal
Business Journal, business-journal.in, 16/07/2021
Mynvax, the “warm” Covid-19 vaccine developed by the researchers at the Indian Institute of Science (IISc), Bengaluru, is effective for all major variants of concern of SARS-CoV2 virus in animal studies. A team of Australian scientists who evaluated the heat-tolerant vaccine developed by a team led by Raghavan Varadarajan a professor at Molecular Biophysics Unit at the IISc found that the recombinant subunit vaccine triggered a strong immune response in mice, protected hamsters from the virus and remained stable at 37 degree Celsius (C) up to a month and up to 90 minutes at 100C. […] CSIRO’s Health and Biosecurity Director, Rob Grenfell, said the pandemic has demonstrated the need for global scientific collaboration to address the urgent demand for multiple cost-effective COVID-19 vaccines and treatments.
Read more: https://business-journal.in/technology/iiscs-mynvax-is-effective-against-all-major-variants-of-concern-study-business-journal/